Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eye Health Among Islet Cell Transplant Recipients With Long-duration Type 1 Diabetes.

Transplantation direct·2026
Same author

Pharmacological inhibition of perforin dampens CD8<sup>+</sup> T cell-mediated beta cell destruction in autoimmune diabetes in mice.

Diabetologia·2026
Same author

KANK1 regulates the positioning of liprin-α1 and the spatial organization of insulin granule fusion in pancreatic β cells.

The Journal of biological chemistry·2025
Same author

LY6H is a marker of human pancreatic delta cells.

Scientific reports·2025
Same author

The future of type 1 diabetes therapy.

Lancet (London, England)·2025
Same author

Twenty years of progress in type 1 diabetes mellitus.

Nature reviews. Endocrinology·2025

Related Experiment Video

Updated: Dec 13, 2025

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

758

IL-17F induces inflammation, dysfunction and cell death in mouse islets.

Tara Catterall1, Stacey Fynch1, Thomas W H Kay1,2

  • 1St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy, Melbourne, VIC, 3065, Australia.

Scientific Reports
|August 6, 2020
PubMed
Summary

Interleukin-17F (IL-17F) contributes to type 1 diabetes by damaging pancreatic beta cells. This cytokine impairs insulin secretion and induces cell death, highlighting its role in diabetes pathogenesis.

More Related Videos

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
12:38

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells

Published on: December 18, 2008

11.5K
Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

35.2K

Related Experiment Videos

Last Updated: Dec 13, 2025

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

758
Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
12:38

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells

Published on: December 18, 2008

11.5K
Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

35.2K

Area of Science:

  • Immunology
  • Endocrinology
  • Diabetes Research

Background:

  • Type 17 immune responses, involving cytokines IL-17A and IL-17F, are linked to type 1 diabetes.
  • Previous research focused on IL-17A's effects on beta cells, leaving IL-17F's role unexamined.

Purpose of the Study:

  • To investigate the pathogenic effects of IL-17F in pancreatic beta cells.
  • To elucidate the mechanisms by which IL-17F impacts beta cell function and survival.

Main Methods:

  • Utilized mouse beta-cell lines and primary islets.
  • Analyzed IL-17F signaling pathways (IL-17RA/RC, Jnk, p38, NF-κB).
  • Assessed gene expression, insulin secretion, and cell viability.

Main Results:

  • IL-17F demonstrated potent pathogenic effects on mouse beta cells and islets.
  • IL-17F suppressed beta-cell identity genes and impaired glucose-stimulated insulin secretion.
  • IL-17F induced beta-cell death via inducible nitric oxide synthase (iNOS) activation.

Conclusions:

  • IL-17F shares pathogenic activities with IL-17A in pancreatic beta cells.
  • IL-17F is implicated as a key factor in type 1 diabetes development.
  • Targeting IL-17F may offer a therapeutic strategy for type 1 diabetes.